Skip to main content
Skip to content
Case File
kaggle-ho-028633House Oversight

Opaque Medical Supply Contracts and Potential Kickbacks Linked to Cardinal Health Amid 2012 Food‑Poisoning Outbreak

Opaque Medical Supply Contracts and Potential Kickbacks Linked to Cardinal Health Amid 2012 Food‑Poisoning Outbreak The passage identifies a possible pattern of undisclosed rebates, confidential pricing, and information sharing between major distributors (Cardinal Health) and manufacturers that could conceal illegal kickbacks. While it lacks specific financial figures, dates, or named officials, it points to a concrete entity (Cardinal Health) and a specific incident (2012 monastery food‑poisoning case) that merit further investigation into contract terms, pricing differentials, and any related payments to hospitals or group‑purchasing organizations. Key insights: Cardinal Health spokesperson cites “disclosure rules” that prevent discussion of costs or prices.; Group‑purchasing organizations handle >50% of U.S. institutional medical‑supply contracts, creating a black‑box pricing environment.; Distributors allegedly sell buyer information back to manufacturers, suggesting a feedback loop that could influence pricing.

Date
Unknown
Source
House Oversight
Reference
kaggle-ho-028633
Pages
1
Persons
0
Integrity
No Hash Available

Summary

Opaque Medical Supply Contracts and Potential Kickbacks Linked to Cardinal Health Amid 2012 Food‑Poisoning Outbreak The passage identifies a possible pattern of undisclosed rebates, confidential pricing, and information sharing between major distributors (Cardinal Health) and manufacturers that could conceal illegal kickbacks. While it lacks specific financial figures, dates, or named officials, it points to a concrete entity (Cardinal Health) and a specific incident (2012 monastery food‑poisoning case) that merit further investigation into contract terms, pricing differentials, and any related payments to hospitals or group‑purchasing organizations. Key insights: Cardinal Health spokesperson cites “disclosure rules” that prevent discussion of costs or prices.; Group‑purchasing organizations handle >50% of U.S. institutional medical‑supply contracts, creating a black‑box pricing environment.; Distributors allegedly sell buyer information back to manufacturers, suggesting a feedback loop that could influence pricing.

Tags

kagglehouse-oversightmedium-importancehealthcare-procurementmedical-supply-pricingcardinal-healthgroup-purchasing-organizationskickbacks

Forum Discussions

This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.

Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.